S-KING(688328)
Search documents
CPO等算力硬件股持续回升,深科达涨超10%
2 1 Shi Ji Jing Ji Bao Dao· 2025-09-25 02:44
Group 1 - CPO and other computing hardware stocks are experiencing a sustained rebound [1] - Deep Science and Technology (深科达) has risen over 10% [1] - Huagong Technology (华工科技) has hit the daily limit up [1] - New Yisheng (新易盛) has increased by over 6% [1] - Zhongfu Circuit (中富电路) and Guangku Technology (光库科技) are among the top gainers [1]
深科达股价涨5.01%,广发基金旗下1只基金重仓,持有20.83万股浮盈赚取30.41万元
Xin Lang Cai Jing· 2025-09-25 01:54
Group 1 - The core stock price of Shenzhen Deep Tech has increased by 5.01% to 30.58 CNY per share, with a total market capitalization of 2.888 billion CNY, and a cumulative increase of 6.63% over the last three days [1] - Shenzhen Deep Tech specializes in the research, production, and sales of flat panel display production equipment, with revenue composition: 49.90% from flat panel display equipment, 27.02% from semiconductor equipment, 22.49% from core components, and 0.59% from other sources [1] Group 2 - According to data, Guangfa Fund holds a significant position in Shenzhen Deep Tech, with Guangfa Baifa Big Data Growth Mixed A Fund (001734) owning 208,300 shares, representing 0.98% of the fund's net value, making it the second-largest holding [2] - The fund has generated a floating profit of approximately 304,100 CNY today and 377,000 CNY during the three-day increase [2] - Guangfa Baifa Big Data Growth Mixed A Fund was established on November 18, 2015, with a current scale of 408 million CNY and a year-to-date return of 30.34%, ranking 3159 out of 8173 in its category [2]
深科达涨2.12%,成交额4220.94万元,主力资金净流入250.53万元
Xin Lang Cai Jing· 2025-09-18 02:36
Company Overview - Shenzhen Deep Science and Technology Co., Ltd. is located in Bao'an District, Shenzhen, Guangdong Province, and was established on June 14, 2004. The company was listed on March 9, 2021. Its main business involves the research, production, and sales of flat panel display production equipment [2]. - The company's revenue composition includes flat panel display equipment (49.90%), semiconductor equipment (27.02%), core components (22.49%), and others (0.59%) [2]. Stock Performance - As of September 18, the stock price of Deep Science increased by 2.12%, reaching 27.96 CNY per share, with a total market capitalization of 2.641 billion CNY [1]. - Year-to-date, the stock price has risen by 86.65%, with a recent 5-day increase of 0.98%, a 20-day decrease of 3.98%, and a 60-day increase of 23.72% [2]. - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent appearance on April 28, where it recorded a net purchase of 4.3555 million CNY [2]. Financial Performance - As of June 30, the company had 6,547 shareholders, an increase of 9.54% from the previous period, while the average circulating shares per person decreased by 8.71% to 14,427 shares [3]. - For the first half of 2025, Deep Science achieved operating revenue of 360 million CNY, representing a year-on-year growth of 49.57%. The net profit attributable to shareholders was 20.6042 million CNY, reflecting a significant year-on-year increase of 180.87% [3]. Dividends and Shareholding - Since its A-share listing, Deep Science has distributed a total of 50.776 million CNY in dividends, with 9.4456 million CNY distributed over the past three years [4]. - As of June 30, 2025, the top ten circulating shareholders of Deep Science saw a change, with the Dazhong CSI 360 Internet + Index A (002236) exiting the list [4].
9月10日晚间重要公告一览
Xi Niu Cai Jing· 2025-09-10 10:38
Group 1 - Dematech won a 900 million yuan overseas smart logistics project from a well-known e-commerce giant in Latin America, focusing on intelligent logistics cross-belt sorting systems and related services [1] - Kang En Bei received approval for the registration of short-term financing bonds and medium-term notes, with a total registration amount of 1 billion yuan, valid for two years [1][2] - Zhi Xiang Jin Tai's GR1803 injection for systemic lupus erythematosus clinical trial has been approved by the National Medical Products Administration [2] Group 2 - Jin Da Wei's subsidiary received approval for a veterinary drug product, pyridone, valid from September 3, 2025, to September 2, 2030 [4] - Fu Li Wang's subsidiary plans to invest 500 million yuan in a high-end wire material project, focusing on high-strength prestressed steel strands for various applications [5] - He Li Biological's subsidiary's Class III medical device registration application has been accepted, focusing on natural bone repair materials [12] Group 3 - Lin Yang Energy won a 244 million yuan metering equipment project from Southern Power Grid, expected to positively impact its 2025 and 2026 performance [20] - Sanxia Water plans to absorb its wholly-owned subsidiary, Chongqing Changdian United Energy, with all assets and liabilities to be inherited by Sanxia Water [13] - Tian Cheng Technology canceled the use of 91 million yuan of raised funds for permanent working capital, ensuring no impact on the normal operation of investment projects [24] Group 4 - Baosteel received approval to publicly issue bonds totaling 20 billion yuan to professional investors, valid for 24 months [52] - Tian Kang Biological reported a 10.15% year-on-year increase in pig sales in August, with a total of 263,800 pigs sold [53] - Xinjiang Construction won multiple major projects totaling 4.506 billion yuan, including a 2.4 billion yuan photovoltaic hydrogen synthesis project [18]
深科达:关于公司高级管理人员增持公司股份计划公告
Zheng Quan Ri Bao Zhi Sheng· 2025-09-09 12:13
Core Viewpoint - The company, Shenke Da, announced a stock buyback plan by its senior management, indicating confidence in the company's future development and long-term investment value [1] Group 1: Stock Buyback Announcement - Shenke Da plans to repurchase its shares based on a stock transfer agreement signed by senior management, Zhou Erqing [1] - The buyback will commence on September 10, 2025, and will last for six months [1] - The total amount for the buyback is set to be no less than 2.88 million RMB and not exceed 4 million RMB [1]
深科达:高级管理人员周尔清拟增持288万元~400万元公司股份
Mei Ri Jing Ji Xin Wen· 2025-09-09 10:30
(记者 王晓波) 2024年1至12月份,深科达的营业收入构成为:电子工业专用设备制造业占比69.88%,核心零部件占比 24.53%,其他收入占比4.79%,其他业务占比0.8%。 每经AI快讯,深科达(SH 688328,收盘价:26.83元)9月9日晚间发布公告称,基于对公司未来持续稳 定发展的信心以及对公司股票长期投资价值的认可,同时根据高级管理人员周尔清先生与公司签署的深 圳线马科技有限公司《股权转让协议》约定购买公司股票的要求,周尔清拟自2025年9月10日起6个月 内,使用其自有资金或自筹资金,通过上海证券交易所交易系统允许的方式增持公司股份,本次合计拟 增持金额不低于人民币288万元且不超过人民币400万元。 每经头条(nbdtoutiao)——雷军挥泪"斩"王腾,小米爱将泄密"失街亭",大厂正风肃纪"拼牙口" 截至发稿,深科达市值为25亿元。 ...
深科达(688328) - 关于公司高级管理人员增持公司股份计划公告
2025-09-09 09:48
证券代码:688328 证券简称:深科达 公告编号:2025-047 深圳市深科达智能装备股份有限公司 关于公司高级管理人员增持公司股份计划公告 直接持股 5%以上股东 是 否 董事、监事和高级管理人员 是 否 其他:__________ 持股数量 0 股 持股比例(占总股本) 0 % 本次公告前 12 个月内 增持主体是否披露增持 计划 是(增持计划完成情况: ) 否 本次公告前 6 个月增持 主体是否存在减持情况 是 否 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 增持主体的基本情况 本次增持主体为深圳市深科达智能装备股份有限公司(以下简称"公司") 高级管理人员周尔清先生。本次增持计划前,周尔清先生未持有公司股份。 增持计划的主要内容 基于对公司未来持续稳定发展的信心以及对公司股票长期投资价值的认可, 同时根据周尔清先生与公司签署的深圳线马科技有限公司《股权转让协议》约定 购买公司股票的要求,周尔清拟自 2025 年 9 月 10 日起 6 个月内,使用其自有资 金或自筹资金,通过上海证券交 ...
深科达(688328.SH)高管周尔清拟288万元至400万元增持公司股份
智通财经网· 2025-09-09 09:41
Core Viewpoint - The company, 深科达 (688328.SH), expresses confidence in its future stable development and recognizes the long-term investment value of its stock, leading to a planned stock buyback by a senior executive [1] Group 1: Stock Buyback Plan - Senior executive Zhou Erqing intends to increase his shareholding in the company starting from September 10, 2025, over a period of six months [1] - The total amount planned for the stock buyback is not less than RMB 2.88 million and not more than RMB 4 million [1]
深科达:高级管理人员周尔清拟增持288万元—400万元公司股票
Zheng Quan Shi Bao Wang· 2025-09-09 09:35
人民财讯9月9日电,深科达(688328)9月9日晚间公告,基于对公司未来持续稳定发展的信心以及对公司 股票长期投资价值的认可,同时根据高级管理人员周尔清与公司签署的深圳线马科技有限公司《股权转 让协议》约定购买公司股票的要求,周尔清拟使用其自有资金或自筹资金,通过上海证券交易所交易系 统允许的方式(包括但不限于集中竞价和大宗交易等)增持公司股份,本次合计拟增持金额不低于288万 元且不超过400万元。 ...
深科达:周尔清拟增持288-400万元
Xin Lang Cai Jing· 2025-09-09 09:31
深科达公告,公司高级管理人员周尔清未持有公司股份,计划自2025年9月10日起6个月内,使用自有或 自筹资金,通过上海证券交易所交易系统允许的集中竞价、大宗交易等方式增持公司A股,拟增持金额 不低于人民币288万元且不超过人民币400万元,增持数量及比例以实际发生为准,增持期间及法定期限 内不减持所持股份。 ...